跳至主要内容
临床试验/TCTR20180606005
TCTR20180606005已完成1 期

Does A Single Low Dose Preoperative Intravenous Erythropoietin Affect Postoperative Blood Loss and Transfusion in Elderly Hip Fracture Patients Receiving Intravenous Iron Therapy: A Prospective Triple-Blinded Randomized Controlled Trial

Ramathibodi hospital0 个研究点目标入组 32 人开始时间: 2018年6月6日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1) aged over 60 years
  • 2) having low-energy trauma
  • 3) having no contraindication for hip fracture surgery
  • 4) willing to participate into this study

排除标准

  • 1) delayed presentation more than 5 days after having injury
  • 2) having myeloproliferative disorder
  • 3) having uncontrolled hypertension
  • 4) having serum creatinine > 2.0 mg/dL
  • 5) having coagulopathy or taking anticoagulant therapy
  • 6) having hemochromatosis
  • 7) having inflammatory arthritis
  • 8) allergic to rHuEPO or intravenous iron sucrose

研究者

相似试验